article thumbnail

Clinical characteristics and mortality risk factors in pediatric hypertrophic, restrictive, and rapidly progressive hypertrophic cardiomyopathy: a retrospective cohort study with follow-up

Frontiers in Cardiovascular Medicine

BackgroundPediatric cardiomyopathies are rare but life-threatening conditions with high mortality. ConclusionsThis study underscores the importance of early diagnosis, genetic testing, and integrated management in pediatric cardiomyopathies. Demographic, clinical, and diagnostic data, as well as follow-up outcomes, were reviewed.

article thumbnail

Clinical presentations leading to arrhythmogenic left ventricular cardiomyopathy

Open Heart

Objectives To describe a cohort of patients with arrhythmogenic left ventricular cardiomyopathy (ALVC), focusing on the spectrum of the clinical presentations. Methods Patients were retrospectively evaluated between January 2012 and June 2020. Results Fifty-two patients (63% males, age 45 years (31–53)) composed the study cohort.

article thumbnail

Normal angiogram one week prior. Must be myocarditis then?

Dr. Smith's ECG Blog

As per my review of this subject ( Check out My Comment at the bottom of the page in the November 16, 2023 post in Dr. Smith's ECG Blog ) — the 3 most common Causes of ACS ( A cute C oronary S yndrome ) with a "negative" cath are: i ) Myocarditis; ii ) Takotsubo cardiomyopathy; and , iii ) MINOCA.

article thumbnail

Bayer to Present New Investigational Heart Failure Data, Continued Portfolio Research in Chronic Kidney Disease at ACC.25

DAIC

Additional ACC.25 Details on abstracts presented by Bayer at ACC.25

article thumbnail

MP-470545-006 TEN-YEAR EXPERIENCE OF THE SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY

HeartRhythm

Hypertrophic cardiomyopathy (HCM) is associated with risk of sudden cardiac death (SCD). Since approval in late 2012, the subcutaneous implantable cardioverter-defibrillator (SICD) has been used as an alternative to the traditional transvenous ICD (TV-ICD) for SCD prevention in HCM.

article thumbnail

PO-02-167 FACTORS IMPACTING SHOCK IMPEDANCE IN SUBCUTANEOUS IMPLANTABLE-CARDIOVERTER DEFIBRILLATORS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY

HeartRhythm

Hypertrophic cardiomyopathy (HCM) is associated with risk of sudden cardiac death (SCD). Since approval in late 2012, the subcutaneous implantable cardioverter-defibrillator (SICD) has been used as an alternative to the traditional transvenous ICD (TV-ICD) for SCD prevention in HCM.

article thumbnail

Outcomes at 1 year in women with peripartum cardiomyopathy: Findings from the ESC EORP PPCM Registry

European Journal of Heart Failure

ABSTRACT Aims There are few prospective reports of 1-year outcomes for women with peripartum cardiomyopathy (PPCM). Methods and results The registry enrolled women from 51 countries from 2012 to 2018. We report findings from the European Society of Cardiology EURObservational Research Programme PPCM Registry.